Related Experiment Video
Updated: Sep 16, 2025

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels
Published on: May 18, 2009
Radioligands Targeting the Purinergic P2X Receptors
Diego Dal Ben1, Michela Buccioni1, Catia Lambertucci1
1School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, Via Madonna delle Carceri, I-62032 Camerino, Italy.
Radioligands targeting Purinergic P2X receptors are crucial for disease research and diagnostics. While in vitro probes exist, in vivo imaging requires further development, though P2X7 antagonists show promise for brain PET scans.
Area of Science:
- Pharmacology
- Neuroscience
- Radiochemistry
Background:
- Purinergic P2X receptors are widely distributed and influence numerous physiological processes.
- These receptors are implicated in diseases including inflammation, neuroinflammation, neurodegeneration, and cancer.
- Developing specific radioligands for P2X receptor subtypes is vital for research and diagnostics.
Purpose of the Study:
- To review and summarize P2X receptor-targeting radioligands developed to date.
- To assess the suitability of these radioligands for in vitro and in vivo applications.
- To highlight advancements in radioligands for P2X receptor imaging.
Main Methods:
- Literature review of P2X receptor radioligands.
- Categorization of radioligands based on target P2X subtype and application (in vitro/in vivo).
- Analysis of radioligand characteristics, including affinity and selectivity.
Main Results:
- A range of radioligands targeting P2X receptors have been developed, from ATP analogues to allosteric modulators.
- Many high-affinity radioligands are suitable only for in vitro studies.
- No viable P2X3 or P2X4 radioligands for in vivo PET imaging have been reported.
- P2X7 antagonists ([11C]SMW139, [11C]GSK1482160, [11C]JNJ-54173717, [18F]JNJ-64413739) have been successfully used for brain PET imaging.
Conclusions:
- P2X receptor radioligands are essential tools for understanding disease mechanisms and developing therapeutics.
- Significant progress has been made in developing P2X-targeting radioligands, particularly for P2X7.
- Further research is needed to develop effective in vivo radioligands for P2X3 and P2X4 subtypes for broader diagnostic applications.
More Related Videos
11:47Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells
Published on: April 3, 2019
08:33Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time
Published on: March 11, 2021
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
GPCR Desensitization
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
GPCRs Regulate Adenylyl Cylase Activity